期刊文献+

Crystal Growth,Structure and Morphology of Rifapentine Methanol Solvate 被引量:3

利福喷丁在甲醇溶剂中的晶体生长、结构与形态研究(英文)
下载PDF
导出
摘要 Rifapentine, an important antibiotic, was crystallized from methanol solvent in the form of its methanol solvate. The crystal structure of rifapentine methanol solvate belongs to monoclinic, space group P21, with the unit cell parameters of a = 1.2278(3) nm, b = 1.9768(4) rim, c = 1.2473(3) nm, Z= 2, and β = 112.35(3). The parallelepiped.morphology was also predicted by Materials Studio simulation program.. The influence of intermolecular in-teraction was taken into account in the attachment energy model. The crystal shape fits the calculated morphology well, which was performed on the potential energy minimized model using a generic DREIDING 2.21 force fieldand developed minimization protocol with derived'partial charges. Rifapentine,an important antibiotic,was crystallized from methanol solvent in the form of its methanol solvate.The crystal structure of rifapentine methanol solvate belongs to monoclinic,space group P21,with the unit cell parameters of a 1.2278(3) nm,b 1.9768(4) nm,c 1.2473(3) nm,Z 2,and β 112.35(3)°.The parallelepiped morphology was also predicted by Materials Studio simulation program.The influence of intermolecular interaction was taken into account in the attachment energy model.The crystal shape fits the calculated morphology well,which was performed on the potential energy minimized model using a generic DREIDING 2.21 force field and developed minimization protocol with derived partial charges.
出处 《Chinese Journal of Chemical Engineering》 SCIE EI CAS CSCD 2012年第3期602-607,共6页 中国化学工程学报(英文版)
基金 Supported by Open Fund of Mineral Resources Chemistry Key Laboratory of Scihuan Higher Education Institutions
关键词 RIFAPENTINE crystal structure morphology CRYSTALLIZATION 溶剂化物 晶体结构 甲醇 晶体生长 形态 能量最小化 能量模型 溶剂结晶
  • 相关文献

参考文献2

二级参考文献47

  • 1Hansen, C.M., "The three dimensional solubility parameter-key to paint component affinities. 1: solvent,plasticizers, polymers and resins", J. Paint Technol., 39,104-117(1967).
  • 2Kreveken, D.V., Properties of Polymers, Elsevier, Amsterdam (1990).
  • 3Li, J.S., Sun, J., Zhang, D.L., "Estimating the solubility parameters of rubber ingredients basing on group contribution", Rubber Eng., 42(7), 393-395(1995). (in Chinese)
  • 4Jenning, V., Gohla, S., "Comparison of wax and glyceride solid lipid nanoparficles", Int. J. Pharm., 196,219-222(2000).
  • 5Sato, K., "Crystallization behaviour of fats and lipids-A review", Chem. Eng. Sci., 56, 2255-2265(2001).
  • 6Hagemann, J.W., Crystallization and Polymorphism of Fats and Fatty Acids, Marcel Dekker Inc., New York (1988).
  • 7Freitas, C., Miiller, R.H., "Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase", Eur. J. Pharm. Biopharm., 47, 125-132(1999).
  • 8Mühlen, A.Z., Schwarz, C., Mehnert, W., "Solid lipid nanoparticles (SLN) for controlled drug delivery-Drug release and release mechanism", Eur. J. Pharm. Biopharm., 45, 149-155(1998).
  • 9Chapman, D., "The polymorphism of glycerides", Chem.Rev, 62, 433-456(1962).
  • 10Mehnert, W., Mader, K., "Solid lipid nanoparticles production, characterization and applications", Adv. Drug Deliv. Rev., 47, 165-196(2001).

共引文献4

同被引文献13

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部